NEWARK, Del.--(BUSINESS WIRE)--SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, today announced that Dr. Klaus Lindpaintner will be joining the Company as Vice President of Research & Development and Chief Scientific Officer (CSO), effective February 1, 2010.
